3 completed. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow Immediate Hypersensitivity: new trials by email Literature Review of Immediate Hypersensitivity trials Research Report on Immediate Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy Peanut powder, Peanut extract, Placebo extract - Peanut Hypersensitivity, Food Hypersensitivity | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 21 | 2010-03-01 | 2017-04-07 |
| Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults E. Coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 - Food Hypersensitivity, Hypersensitivity | Phase 1 | Completed | Allertein Therapeutics, LLC | 15 | 2009-10-01 | 2013-05-27 |
| A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial Glycerinated peanut allergenic extract, Placebo for peanut extract (glycerin) - Food Hypersensitivity, Hypersensitivity | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 40 | 2007-12-01 | 2019-08-21 |
Food Hypersensitivity (3) · Hypersensitivity, Immediate (3) · Peanut Hypersensitivity (3) · Hypersensitivity (2)
Immune System Diseases (3) · Nut and Peanut Hypersensitivity (3) · Hypersensitivity (1)
Glycerol (1)
Allertein Therapeutics, LLC (1) · Johns Hopkins University (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (3)
Robert Wood, MD (2) · David Fleischer, MD (1) · Hugh A. Sampson, MD (1) · Robert A. Wood, MD (1) · Scott Sicherer, MD (1) · Stacie Jones, MD (1) · Wesley Burks, MD (1)